Berkshire Hathaway set to acquire OxyChem in $10B deal: report

Berkshire Hathaway is reportedly nearing a $10 billion acquisition of OxyChem, a division of Occidental Petroleum, which would mark its largest deal since 2022. This potential transaction would deploy a portion of Berkshire's record $344 billion cash reserves and significantly deepen its existing investment in Occidental, where it already holds a 28.2% equity stake, despite Warren Buffett's prior assertions against a full takeover. The deal, which could finalize within days, saw Occidental shares edge up 0.4% on the news.

Analysis

Berkshire Hathaway's reported agreement to acquire OxyChem from Occidental Petroleum for approximately $10 billion represents a significant strategic capital deployment. For Berkshire, this move utilizes a fraction of its record $344 billion cash reserve in what would be its largest acquisition since 2022, signaling a re-engagement in large-scale deal-making. The acquisition of a specific operating division deepens its conviction in Occidental, where it already holds a 28.2% equity stake, without pursuing a full takeover, which aligns with Warren Buffett's prior public statements. For Occidental Petroleum, the divestiture provides a substantial capital infusion. However, the market's muted reaction, with OXY shares rising just 0.4%, suggests investors are weighing the immediate cash benefits against the future earnings loss from the chemicals division, indicating a neutral to slightly positive valuation impact from the deal.

Key Decisions for Investors

• Investors in Berkshire Hathaway should view this transaction as a constructive use of its large cash position, reinforcing the thesis that management is actively deploying capital into productive assets within its circle of competence.
• For Occidental Petroleum shareholders, the key focus should be on management's planned use of the ~$10 billion in proceeds, as its allocation toward debt reduction versus shareholder returns will be a critical determinant of future equity value.
• The structure of the deal as an asset purchase, rather than a full corporate takeover, likely limits the potential for a near-term control premium for Occidental's stock but solidifies Berkshire's position as a long-term strategic partner.